CAR T-Cell Therapy Drives Refractory SLE Into Remission CAR T-Cell Therapy Drives Refractory SLE Into Remission

B-cell depletion with chimeric antigen receptor T cells induced both serologic and clinical remissions in a patient with treatment-resistant lupus.Medscape Medical News
Source: Medscape Dermatology Headlines - Category: Dermatology Tags: Rheumatology News Source Type: news